Haiti vs Myanmar: HIV/AIDS deaths averted by antiretroviral therapy
Haiti
8,513 deaths
in 2024
Myanmar
8,848 deaths
in 2024
Haiti rank
27th
Myanmar rank
26th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Haiti
- Myanmar
How they compare
Myanmar currently reports 8,848 deaths against 8,513 deaths in Haiti, a difference of 335 deaths.
The two have swapped places 2 times across 35 shared years of data; in 1990 it was Myanmar ahead.
Haiti ranks 27th and Myanmar ranks 26th of 157 countries.
Across the 4 decades both report, Haiti averaged higher in 1 and Myanmar in 2.
Head to head by decade
| Decade | Haiti | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 1,003 deaths | 792.59 deaths | 210.39 deaths | Haiti |
| 2010s | 4,307 deaths | 7,079 deaths | 2,772 deaths | Myanmar |
| 2020s | 8,123 deaths | 9,387 deaths | 1,264 deaths | Myanmar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Haiti or Myanmar?
- Myanmar, at 8,848 deaths against 8,513 deaths in Haiti as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Haiti and Myanmar?
- 335 deaths, with Myanmar ahead.
- How many years of comparable data are there for Haiti and Myanmar?
- 35 years are reported by both, from 1990 to 2024.
- How do Haiti and Myanmar rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Haiti ranks 27th and Myanmar ranks 26th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.